PENG block & early mobilization following THA

JRCT ID: jRCT1030240537

Registered date:10/12/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: total hip arthoplasty
• Date of first enrollment: 10/12/2024
• Target sample size: 1000
• Study type: Other
• Intervention(s): pericapsular nerve group (PENG) block

Outcome(s)

Primary Outcome

time to first mobilization
(Details regarding the outcome definitions are provided in the uploaded PDF file.)

Secondary Outcome

(1) QoR-15 and QoR-40 score on POD1
(2) QoR-15 and QoR-40 score on POD2
(3) Quadriceps strength
(4) Hip range of motion
(5) Dynamic pain
(6) Patient satisfaction
(7) Hospital length of stay
(8) Postoperative complications, where reported
(Details regarding the outcome definitions are provided in the uploaded PDF file.)

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Eligible studies included randomized controlled trials, where (1) adult patients who received total hip arthroplasty under either general or spinal anesthesia;(2) patients were randomized to PENG block (ultrasound-guided, X-ray-guided, or CT-guided or landmark-based techniques) as an intervention compared with any kind of analgesia management other than PENG block (including no block, sham block, local or intraarticular anesthetic infiltration, or any other peripheral neural block). Published and unpublished articles, abstracts of conferences, and letters were included. No language restrictions were applied.
• Exclude criteria: Exclusion criteria include: (1) studies that had another block as a co-intervention, except for lateral femoral cutaneous nerve (LFCN) block or infiltration using local anesthetics; (2) studies of catheter-based continuous blocks; (3) studies where both intervention and comparison were PENG block; (4) studies with data that could not be used for statistical analysis, or studies with incomplete data, or data that could not be extracted after contacting the original authors; and (5) studies that were duplicate publications

Related Information

• Primary Sponsor: Jin Zhuan